Sunday 22 December 2019

Global Biohacking Market Is Segmented Into Outside And Inside Biohacking

Biohacking Market Overview
The trend for treatment customization has become increasingly popular in recent times giving way to robust growth in the Biohacking Market. Reports that gauge the healthcare industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is projected to capture a 19.42 % CAGR in the duration of the forecast period.

The popularity of biohacking as a do-it-yourself (DIY) biology procedure is gaining increasing demand from individuals who are knowledgeable enough to decide their treatments. Moreover, the increased frequency of chronic diseases coupled with the demand for smart devices is expected to encourage the development of the biohacking market. Also, the biohacking market is expected to increasingly profit in the coming years due to the implementation of the internet of things (IoT) in fitness, healthcare, and consumer electronics.
Segmental Analysis
The segment evaluation of the biohacking market is conducted on the basis of type, product, region, application and end users. On the basis of type, the biohacking market comprises of outside biohacking and inside biohacking. Based on the product, the biohacking market can be segmented into sensors, smart drugs, strains, and others. On the basis of applications, the biohacking market can be segmented into genetic engineering, synthetic biology, forensic science, drug testing, diagnosis & treatment, and others. The segmentation of the biohacking market on the basis of end users comprises of forensic laboratories, pharmaceutical & biotechnology companies, and others. Based on the regions, the biohacking market is segmented into Europe, the Americas, Asia Pacific, the Middle East, and Africa.
Detailed Regional Analysis     
The regional analysis of the biohacking market includes regions such as Europe, the Americas, Asia Pacific, the Middle East, and Africa. The Americas region with a market worth of USD 2999.05 million, is currently the market influencer and is anticipated to increase to USD 10573.53 million in the forecast period which can guarantee their position as the market leader. The presence of a huge number of synthetic biology and biotechnology companies in the region is the key reason for the region’s supremacy. In addition, the youth from the region are more conscious of the far-reaching impacts of the market which operates as a motivator for the market. Though, the Asia Pacific region is not far behind in gaining impetus and can grow a CAGR of 19.91% during the forecast period. The region has a vast patient pool afflicted with constant diseases that are impacting the regional market in a significant way. The evolving economies such as China and India are also making notable efforts in revamping their medical infrastructure which can, as a result, boost the market’s expansion in the forecast period.
Competitive Analysis
The advancement of the market is projected to capture amplified impetus in the coming years chiefly due to the incidence of contributory government plans. The escalated turnaround in the market is likely to set off new openings for the development of the market. The enhancement in different domestic economies is projected to encourage the progress of the market in the impending period. The ease in accessing key planned opportunities important to consequent stabilization of inflation is projected to generate a promising option for development in the approaching years. In the approaching years, the control exerted by fairly high-income level nations around the world and the likely gains observed towards a few of the currencies around the world is projected to strengthen the fruition of the market in the forecast period. A significant climb in the number of backers in the market is expected to craft an advantageous state of affairs for the evolution of the market in the projected period.
The chief companies outlined in the report are HVMN, Inc., ODIN, Synbiota, Apple, U.S.A., Moodmetric, Thync Global Inc. and Fitbit, Inc., to name a few.
Read Complete Report @ http://marketresearchfuture.com/reports/biohacking-market-5155

Trending Reports
Medical Tourism Market Research Report - Global Forecast till 2023

Patient Access Solutions Market Research Report - Forecast to 2024

Acupuncture Market Research Report – Forecast to 2023




Posted by at No comments:
Labels: , , ,

Thursday 19 December 2019

Duloxetine API Market Synopsis and Highlights, Key Findings, Major Companies Analysis and Forecast to 2023

MRFR Press Release/- Market research future will be publishing a cooked research report on “Global Duloxetine API Market” that contains the information from 2015 to 2023. The global duloxetine API market is expected to register at a CAGR 3.52% during the forecast period of 2018 to 2023
Market Research Future (MRFR) recognizes the following companies as the key players in the global duloxetine API market that includes Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Aurobindo Pharma (India), Lupin (India), Zydus Cadila (India), Eli Lilly and Company (United States), Shodhana Laboratories (India), Hetero (India), Apotex Inc. (Canada), Shionogi Inc. (US), and Zhejiang Huahai Pharmaceutical Co., Ltd (China)
Market Highlights
The global duloxetine API market is expected to register a CAGR of 3.52% and is anticipated to reach USD 3,985.0 million by 2023. Active pharmaceutical ingredients (APIs) are used in the manufacturing of pharmaceutical dosage forms such as tablets and capsules. Duloxetine is a serotonin-norepinephrine reuptake inhibitor used in the treatment of depression and anxiety. Additionally, duloxetine API is used to help relieve neuropathic pain in people with diabetes or ongoing pain due to disease conditions such as arthritis, fibromyalgia, and chronic back pain.
The factors such as the rising prevalence of depression, growing penetration of generic drugs, growing cases of anxiety, the growing trend of outsourcing, strong drug pipeline, and increasing demand for newly developed small molecule drugs are expected to drive the market growth during the forecast period.
Segment analysis
The global duloxetine API market has been segmented into application. Based on application, the market has been segmented into major depressive disorder, generalized anxiety disorder, fibromyalgia, neuropathic pain, chronic musculoskeletal pain, and others. The chronic musculoskeletal pain accounted for a market value of USD 200.0 million in 2017.
Regional Analysis
Geographically, the Americas is expected to dominate the global duloxetine API market. In this region, North America is expected to dominate the market owing to the increasing incidence of chronic diseases such as psychological disorders, diabetes, increasing government focus on generic drugs, and technological advancements in the manufacturing processes of APIs. In Europe, the market growth is majorly due to the increasing pharmaceutical sector. Additionally, in Europe, countries such as the UK, Germany, and France have a higher demand for API and thereby drive the growth of the overall market. The Asia-Pacific market for duloxetine API is considered to be growing significantly due to the rising healthcare spending and a growing number of contract manufacturing organizations (CMOs). In this region, Japan accounted for a market share of 13.7% in 2017. Moreover, the Middle East and Africa accounted for the least share of the market. The low market share is due to the limited number of companies manufacturing duloxetine API.
Key Findings of the Study:
  • Global duloxetine API market is projected to reach USD 3,985.0 million by 2023 with 3.52% CAGR during the review period of 2018 to 2023.
  • Americas accounted for the largest share in the region due to the rapidly growing prevalence of anxiety and depression.
  • Some of the players operating in the duloxetine API market include Lupin, Teva Pharmaceutical Limited, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Lupin, Zydus Cadila, among others.
This research report provides insights, on various levels of analysis such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global duloxetine API market, including the high-growth regions and their political, economic, and technological environments. Furthermore, the project report also provides views over historical market values as well as, pricing and cost analysis of the same.
Latest Trending Report
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Myasthenia Gravis Market to Witness Rapid Increase in Consumption During 2018-2023

Myasthenia Gravis Market Overview:
The latest study conducted by Market Research Future (MRFR) reveals the global Myasthenia Gravis (MG) Market is set to witness 9.61% CAGR during the assessment period (2018-2023) and surpass a valuation of USD 3,000 Mn.  Factors such as increased prevalence rate, investment in R&D and advances in healthcare are likely to support the growth of the market. In recent years, a sharp rise in MG and related incidences has been noticed. In advanced countries, a greater level of awareness prevails, which is favoring the market’s growth. It is understood that early diagnosis and treatment can reduce the impact of the condition to a significant extent, however outcomes may vary from case to case.
Advances in technology has resulted in development of therapeutics that are more effective as compared to traditional medicines. At the same time, increased level of awareness among patients and government support in product research & development is expected to create market opportunities in forthcoming years. Nonetheless, high cost of treatment is currently viewed as the primary restraint for the markets 

Segmental Analysis

The report includes a segmental analysis of the market, which covers disease type, end-user, diagnosis and treatment and region. By type, the market has been segmented into congenital myasthenia gravis, transient myasthenia gravis, ocular myasthenia gravis, generalized myasthenia gravis and others. The generalized myasthenia gravis segment accounts for the dominant share of the market. The segment currently stands at market valuation of USD 700 Mn and is likely to reach USD 1526.66 Mn by 2023, reflecting a healthy CAGR. This primarily owing to the widespread prevalence of generalized myasthenia gravis. By diagnosis and treatment, the market has been into diagnosis and treatment. Sub-segments of the diagnosis segment that are discussed in the report are electrodiagnostic testing, imaging and Lab-based test. Sub-segments of the treatment segment discussed in the report are plasmapheresis and intravenous immunoglobulin, immunosuppressive drugs, thymectomy and cholinesterase inhibitors. The treatment segment is expected to highly profitable over the next couple of years. The segment currently accounts for nearly two-third share of the market and expected to capture 9.52% CAGR during the forecast period. By end user, the market has been segmented into academic and research organizations, diagnostic centers and hospitals and clinics. The hospitals and clinics segment commands the largest market share in terms of value.
Regional Analysis
The regions that are covered in the report are Europe, Americas, Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, Americas captured the largest market share in terms of value. The region is likely to retain its dominance over the review period. There are several factors that can be linked with the region superior position, the prominent ones being existence of a world-class healthcare system, particularly in countries such as the U.S. and Canada, rising healthcare spending and availability of a wide rang of treatment options. The region is followed by Europe and Asia Pacific respectively. The market in Europe is currently valued at USD 675.12 Mn and expected to record a steady growth over the review period. Meanwhile, Asia Pacific is expected to post the highest CAGR over 2023. Presence of a massive patient pool and rising geriatric population is driving the market’s growth in APAC. Additionally, countries such as India and China are undergoing policy overhaul, to improve the socio-economic elements. As a result, a number of sectors, including the healthcare have witness tremendous transformation. Such changes are opening new avenues for market players functioning in the region.
Myasthenia Gravis Market: Competitive Landscape
Global players mentioned in MRFR’s report include GE Healthcare, Novartis AG, Boston Scientific Corporation, Grifols S.A., Koninklijke Philips N.V., Alexion Pharmaceuticals, Inc. Valeant Pharmaceuticals International, Inc., Pfizer Inc., Medtronic Plc., Shire, CSL Behring and Baxter.
Trending Reports
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Tuesday 10 December 2019

Medical Marijuana Industry 2023: What Current Study say about Top Companies like Canopy Growth Corporation (US), Cannabis Sativa Inc (Nevada), GW Pharmaceuticals Plc (US), Emerald Health Therapeutics.. – Industry Reports

Often scoffed at for its adverse impacts on health, marijuana is now getting the pats for having healing components. The medical marijuana market is benefiting from it.
One major reason for the medical marijuana market’s surge is the rising cognizance of its medicinal impact among the medical fraternity. In fact, in West Virginia, the West Virginia Department of Health and Human Resources (DHHR) Bureau for Public Health would start accepting applications for medical marijuana permits from growers, processors, laboratories, and dispensaries. It will help the market in creating a niche customer base and register a 34% CAGR between 2018 and 2023, which is the forecast period as per Market Research Future (MRFR). The time would also witness a rise in marijuana market size to a valuation of USD 54,677.1 million by 2023.


Chronic Diseases to Strengthen its Acceptance
Marijuana has been well-lauded by companies for its chemical compounds like Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC carries psychedelic properties. Its intake in treatment for chronic diseases like Alzheimer’s disease, Crohn’s disease, and cancer is creating scope for the market to expand. In November 2019, Medlab launched NanaBis, a drug with cannabidiol to cure pain for the test, which is getting good results and can be considered positive for the market.

Research to Find Favor from Surging Investment
Its potential is well-documented and various countries are already on the wagon to explore opportunities that the medical marijuana industry has to offer. The marijuana market research is finding an influx of investment from both government and private bodies well-suited for growth.

DEA Can Hold Back Growth
The Medical Marijuana Industry Statistics is facing hurdles set by the U.S. Drug Enforcement Administration (DEA), which takes Marijuana as a Schedule I drug sharing the same league with LSD, heroin, and ecstasy. However, a study in 2013, conducted by the New England Journal of Medicine revealed that 8 out of 10 doctors are preferring medical marijuana and 92% of patients have said that they felt better after its application. This can bring back the medical marijuana business back on track.

Product Type, Application, and Distribution Channel: Major Segments
Players involved with the growth of the market could benefit from an effective segmentation of the medical marijuana market.

Dissolvable/Powders Leads the Type Segment
The global medical marijuana market can be segmented by type into solids, dissolvable/ Powders, oil, ointments & creams. Affordability and convenience can assist dissolvable/ powders to attain the predicted valuation of USD 22,648.8 million by 2023.

Chronic Diseases to Inspire Application-Wise Growth
The market has prominent diseases like Alzheimer’s disease, cancer, schizophrenia, and multiple sclerosis that eases market understanding. But chronic diseases like Alzheimer’s disease and cancer have better market understanding.

Segments by Distribution Channel
The global market for medical marijuana to include online platforms, retail & pharmacy stores, and others to facilitate a better study.

The Americas Market to Take the Lion’s Share
The market can be segmented into North and South of which the North would claim the maximum share. This is due to growth in Canada and the US, where legalization is happening at a rapid pace and research supporters are providing huge traction to the market by increasing funding. Pharmaceutical companies are leading the motion.

Competition
The medical marijuana market size would receive boost from active participation of Cannabis Sativa Inc (Nevada), Canopy Growth Corporation (US), Emerald Health Therapeutics Inc. (Victoria, BC), GW Pharmaceuticals Plc (US), Aphria (Ontario), Tilray (Nanaimo, BC), Cara Therapeutics (US), GBSciences Inc. (Nevada) CanniMed Ltd (Canada), Medical Marijuana Inc (US), Pfizer Inc. (US), and MediPharm Labs (US).

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Tuesday 3 December 2019

Hair Transplant Market Perceives Accrue of USD 23,881.9 Million by 2023 At 24% of A CAGR; Asserts MRFR

Hair Transplant Global Market   - Overview
The Global Hair Transplant Market is growing with the rapid pace; mainly due to the increasing demand for Hair Transplant treatments and introduction of advanced technology in the Hair Care and Hair Rejuvenation industry.  According to a recent study report published by the Market Research Future, The global market of Hair Transplants booming and expected to gain prominence over the forecast period. The global hair transplant market is expected to reach USD 23,881.9 million by 2023 from USD 4,128.1 in 2016 with a CAGR of 24 % for the forecasted period. The numbers indicate that the market is going to grow in multi folds.

The market for Hair transplant is mainly driven by Social and cultural factors such as influence of media, fashion and film industry, peer pressure for appearance and beauty, changing dimensions of beauty etc. The growth of the tourism industry and formation of tourism clusters have not only increased exposure to Hair Transplant but have also created a high point demand for these treatments. There has been rising trend of Hair Transplant with a hefty 40% growth with men especially for beard. Additionally, health factors such as accidents, the safety margin that the treatment offers, and the growing number of Hair Transplant hospitals etc. are providing impetus to the market growth of Hair Transplant. Moreover technological factors such as development of advanced technologies like robotics hair-transplant are fostering the market growth further. Also, the fact that some Financing agencies, hair-transplant clinics and other medical practitioners who offer Hair Transplant procedure also offer easy financing plans; this factor also adds on the market growth of Hair Transplant market.  

Appearances are important, our hair represents our personality and a head full of thick hair/mane is accountable for almost 80% of beauty.  The deep personal relationship between hair and self-esteem is evident throughout history, philosophy and even religion. Everyone strives to have Shiny, thick and Healthy Hair.  And this very desire catalyzes the notion of Hair Transplant.
Hair Transplant refers to a surgical technique that extracts hair follicles from a part of the body to a balding part. It is primarily used to treat male pattern baldness. In this minimally invasive procedure, grafts containing hair follicles that are genetically resistant to balding. Back of the head are transplanted to the bald scalp. 


Hair Transplant Market   - Competitive Analysis
Characterized by the presence of several well-established players having regional and international presence, the global Hair Transplant Market appears to be highly competitive yet consolidated. Well established players incorporate acquisition, collaboration, partnership, expansion, and technology launch in order to gain competitive advantage in this market and to maintain their market position. These key players compete based upon pricing, Technology and services. Hair Transplant market demonstrates a high growth potential which is likely to attract many entrants to the market resulting in to intensified competition further with an increase in service extensions, technological innovations. To gain the competitive edge and to stay abreast in the market; marketers ensure that the information about Hair Transplant procedures is provided thoroughly to the client only by a well-trained surgeon. They strive to offer uniquely customized solutions to reflect specific aesthetic preferences. These Key Players also ensure to provide the best possible patient care throughout Hair Transplant experience.
Hair Transplant Market   - Segments
Global Hair Transplant Market is segmented in to 4 Key dynamics for an easy grasp and enhanced understanding.
Segmentation By Surgical Methods  : Comprises - Follicular Unit Transplantation (FUT), Follicular Unit Extraction (FUE) and other.
Segmentation By Type of Surgery     : Comprises - Head Hair Transplant, Eyebrow Transplant, Frontal Hairline Lowering or Reconstruction and other.
Segmentation By End User                : Comprises - Trichology Clinics, Hospitals, Dermatology Clinics, and other.
Segmentation By Regions                   : Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

Follicular Unit Transplantation segment accounts for the largest market share with 52.7 % of the global hair transplant market by method.
Head hair transplant segment accounts for the major share of 88.3% in the market of hair transplant.
Trichology clinics accounts for the largest market share in global hair transplant market by end users and is expected to reach USD 14,193.7 million by 2023.

Hair Transplant Market   - Regional Analysis
Considering the global scenario of the market, the Americas is holding the largest market share. This market was valued at USD 2,240.7 Million in 2016. Asia Pacific is the second largest and fastest growing market and expected to grow at a CAGR of 24.3% during the forecast period. Europe hair transplant market is also growing significantly. The west European countries like Germany, France, and UK are holding major market share. While UK is believed to be fastest growing market for hair transplant in European region. Europe hair transplant market is expected to reach USD 3,647.3 million by 2033. Due to lack of knowledge of treatments, Middle East & Africa market for hair transplant is expected to grow at a steady pace.

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels: , , ,

Dental CAD/CAM Global Market Research Report | Global Trends, Demand, Size, Business Development and Forecast to 2027

Dental CAD/CAM Global Market Highlights
The global dental CAD/CAM market has been evaluated as rapidly growing market and expected that the market will reach high growth figures. There has been a tremendous growth in the adoption rate of the CAD/CAM systems in the field of dental science. Due to the benefits offered by the dental CAD/CAM systems such as high precision, enhanced speed of the process of restorations, there has been huge demand for dental CAD/CAM in the dental laboratories as well as dental clinics and it has a high importance in the market. People are now more aware about the aesthetic value of the teeth, and are willing to spend a good sum of money for the dental replacements and fixtures using implants and prosthetics. Due to this, there has be growth in the dental cosmetic surgeries ultimately helping in boosting the revenues in the dental CAD/CAM market. The cosmetic dentistry market value is estimated to surpass $20 billion mark by the year 2022.

There are dental service organizations which enable dentists to invest in the new technologies and help dentists incorporated these technologies into practice. The growth in the DSOs has been crucial in driving the dental CAD/CAM market. Dentists are now using variety of dental materials for the restorations. The materials are used according to the type of restoration, cost of the material, patient budget and durability of the material. The variety in the material and it’s affordability has lead people to undergo restoration procedures.
On the other hand, the initial investment in the dental CAD/CAM systems are around USD 60,000+. These complicated systems need regular maintenance in order to work efficiently where the maintenance cost is also way too high. Burden of this high costs compels small scale dentists to make crunching calculations on potential return of investments. Small capital and high cost raises the affordability issues for the dentists. This factor can hamper the growth of the dental CAD/CAM market.  

Regional Analysis:
Depending on geographic region, dental CAD/CAM market is segmented into four key regions: North America, Europe, Asia Pacific, and Middle East & Africa. Globally Europe is the largest market for dental CAD/CAM. The Europe market for dental CAD/CAM is expected to reach at USD 1.45 Billion by the end of the forecasted period. North America is the second-largest market for dental CAD/CAM which is expected to grow at a CAGR of 8.3%. Asia pacific region is expected to be fastest growing region in dental CAD/CAM market.

Dental CAD/CAM Global Market   - Competitive Analysis
Characterized by the presence of several major well-established players, the global Market of Dental CAD/CAM appears to be highly competitive. Players operating in the global Dental CAD/CAM markets are focusing upon optimized situational awareness for customers and ensure their mission success. Well established players increasingly seeking market expansion through various strategic mergers and acquisitions, innovation, increasing investments in research and development and cost-effective product portfolio. Strategic partnerships between Key players support the growth and expansion plans of the key players during the forecast period. These players possess state of art developing labs for CAD/CAM and strong sales and distribution network which have helped them to gain leadership position in the market. An ever-increasing emphasis has been observed among dental industry marketers on inbound lead generation over branding-oriented efforts.

Dental CAD/CAM Global Market   - Segmentation
The Dental CAD/CAM Market can be segmented in to 5 key dynamics for the convenience of the report and enhanced understanding;
Segmentation By Type of Product    : Comprises In-Lab system, In-office system and other.
Segmentation By Application            : Comprises Crowns, Dentures, Bridges, Veneers & Inlays/Onlays and other.
Segmentation By Component           : Comprises Equipment, and CAD/CAM among others.
Segmentation By End User                : Comprises Dental Laboratory, Dental Clinic, Research/Academic institute among other.
Segmentation By Regions                 : Comprises Geographical regions - North America, Europe, APAC and Rest of the World.
Segment Equipment holds the largest share of 89% of the market.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to understand and simplify the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR) and Market Research & Consulting Services.

MRFR team stringently holds  the objective to provide optimum quality market research and intelligence services to its clients. Our market research studies about products, services, technologies, applications, end users, and market players for global, regional, and country level market segment enabling our clients to see more, know more, and do more, which helps them in getting answers for their each and every  important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meeting with the industry experts and does industrial visits for its research analyst members.

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Tuesday 26 November 2019

3D Printed Medical Implants Market by Component Type: Materials, Services, System

Market Highlights
The global 3D printed medical implants market held a market value of USD 1,124.68 million in 2018 and is projected to grow at a CAGR of 18.1% over the forecast period.   
3D printing is a procedure that uses a layer by layer method for the creation of a real or physical object from a digital design. This technology is in its early stage in healthcare applications and holds strong potential for a wide variety of applications in medical implants. Factors such as vast technological advancements in the medical device industry and strategic investments done by leading players are expected to drive the market growth. For instance, EnvisionTEC signed a partnership with Abergower as its global reseller partner to expand Envision’s global footprints in 3D printed medical devices market in November 2017. Moreover, the rising need for medical implantation due to the high prevalence of bone-dental disorders are driving the growth of the global 3D printed medical implants market.

On the other hand, the high cost of implants and stringent government regulations are likely to hamper the growth of the market.
Segmentation
The global 3D printed medical implants market has been segmented into component type, implantation technology, application, and end user.
By implantation technology, the market has been segmented into laser beam melting, electronic beam melting, droplet deposition, and others.
Based on application, the market has been segmented into dental, orthopedic, and cranio-maxillofacial.
The market, by end user, has been segmented into hospitals, medical device companies, research and academic institutes, and others.
Key Players
  • Materialise
  • Renishaw PLC
  • 3D Systems, Inc.
  • Stratasys Ltd
  • ENVISIONTEC, Inc.
  • Arcam AB
  • SLM Solutions
  • Oxford Performance Materials
  • Bio3D Technologies
  • Cyfuse Biomedical K.K.
  • TRUMPF
  • ADEISS
  • OsseoMatrix
  • AnatomikModeling
  • EIT Emerging Implant Technologies
  • Others

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , ,

Thursday 14 November 2019

Healthcare Supply Chain Management Market- Latest Trends, Demand and Future Growth by 2023


This report categorizes the Healthcare Supply Chain Management Market data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors Analysis. 
Market Overview
The Global Healthcare Supply Chain Management Market was analyzed by Market Research Future (MRFR) and it was projected that a noteworthy CAGR of 8.2% will be attained by the market over the forecast period of 2018 to 2023. The valuation of the healthcare supply chain management market was further stated to surpass its previous valuation by the end of 2023.


The major factors of growth for the market are an expanding number of businesses, fast product lifecycle, increasing fragmentation in the healthcare sector, rising globalization rate, high economy of scale, and others. Some of the other factors influencing the market are surging customer demand, increasing rate of customization, advancing capabilities of technologies, and others. However, factors like low innovation, lack of awareness among individuals, high cost associated with maintenance and installation, and issues concerning integration can limit the growth of the market over the forecast period.

Regional Analysis
The global healthcare supply chain management market is geographically distributed across the following key regions: Asia Pacific, North America, Europe, and the Middle East & Africa.
The Americas is projected to lead the global healthcare supply chain management market due to an established healthcare sector, favorable government initiatives, the presence of a number of leading biotech and pharmaceutical organizations, growing in demand for medical devices and increasing technological advancement. The medical devices exportation and the generation of a huge sum of revenue is aiding the supply chain management in the healthcare sector in the Americas.
Europe is said to be the second largest region in the global healthcare supply chain management market. According to the European Commission publication of 2017, Europe was one of the leading exporters of pharmaceutical as well as medicinal products. Add to this, in 2016, European market accounted for EUR 144 billion, by exporting pharmaceutical products across the globe. The rising import and export activities for healthcare related products is slated to boost the market in this region.  
Asia-Pacific is primed to be the fastest growing region in the market for healthcare supply chain management. This is due to the increasing prevalence of chronic disease and a considerable increase in the demand for pharmaceutical and medical products. Additionally, the increasing expenditure in the healthcare industry is anticipated to accelerate the growth of the regional market.
Lastly, the Middle East & Africa stands with the lowest share of the market. A major share of this regional market is reported to be held by Middle East because of a comparatively developed healthcare sector and increasing number of government initiatives to enhance the healthcare sector.

Market Segmentation
The global healthcare supply chain management market has been segmented in terms of technology, models, function, end-user, delivery mode, and software.
By models, the market branches into make-to-stock model, build-to-order, chain assembly, continuous replenishment model, and others.
By function, the market is divided into warehousing and distribution, forecasting and planning, reverse and extended logistics, internal logistics and operations, inventory management and procurement, and others.
By delivery mode, the market segments into web-based, on-premise, and others.
By software, the market breaks down into planning and execution tools. The planning tools segment is narrowed down into supplier and vendor management, forecasting and inventory management, production and sales planning, others. While the execution tools segment is narrowed down into order processing and status tracking, warehouse management, and others.
By technology, the market comprises radio frequency identification (RFID), barcode, internet of things and big data, global positioning system (GPS), and others.
By end users, the market includes logistics companies and distributors, pharmaceutical and biotech companies, healthcare providers, and others.


Competitive Landscape
The global healthcare supply chain management market comprises a host of key players. This includes names like Jump Technologies (US), SAP (Germany), TECSYS (Canada), McKesson (US), Infor (US), Oracle (US), GHX (US), LogiTag Systems (Israel), JDA Software (US), JDA Software (US), Manhattan Associates (US), and others.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Top 10 Key Players Focus On Dietary Supplements in the Age of Personalized Nutrition Market

Dietary Supplements in the Age of Personalized Nutrition Market Overview:
In recent years, the dietary supplement market has witnessed tremendous growth. The major factors influencing the growth of the market include rapid diversification and rising prevalence of various lifestyle diseases worldwide, rising approval from government bodies, growing awareness, and screening for diabetes mellitus, rise in research funding for diagnosis and treatment of these conditions. Furthermore, increasing government healthcare expenditure for the welfare of the population, has spurred the growth of this market.


Healthcare expenditure across the globe is continuously increasing. From the last decades, healthcare expenditure in regions like the Americas and Europe has increased. According to the Centers for Medicare & Medicaid Services, in 2015, the U.S. healthcare spending is likely to increase 5.8% reaching USD 3.2 trillion. Since 2016, the healthcare spending in North America has been increased. Canadian healthcare specifically was stressed by an advancing demographic move. Therefore, growing healthcare expenditure.
Increasing incidence of diseases due to sedentary lifestyle and a lack of balanced diet has majorly influenced the growth of the market. According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all global deaths. According to the same study, it was found that 82% of the total deaths occurred in the low and middle-income countries. Dietary supplements in the age of personalized nutrition plays an important role in the treatment of various lifestyle diseases such as atherosclerosis, cardiovascular disease, stroke; obesity and type 2 diabetes due to which there has been an increasing demand for dietary supplements in the age of personalized nutrition. Changing the dietary approaches and switching to therapeutic lifestyle prove effective in the prevention of hypertension and other cardiovascular disorders. Furthermore, many organizations such as the America Heart Association and the National Heart, Lung and Blood Institute have come up with strategic diets to minimize the risks for cardiovascular and other lifestyle related diseases.


Some of the key players in this market are Nestlé Health Science, Danone Nutricia, Carlyle Group, Amway (Nutrilite), Archer Daniels Midland, Abbott Laboratories, Herbalife International, Amway, Danisco, Glanbia, Bayer AG, GlaxoSmithKline plc, Pfizer Inc., Balchem Corporation, Natures Product Inc., Bactolac Pharmaceutical Inc. and others.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: ,
Subscribe to: Posts (Atom)